Meeting
2016 Gastrointestinal Cancers Symposium
Impact of relative dose intensity and G-CSF use in the adjuvant treatment of resected colon cancer.
Authors
Daniel Adam Breadner
Schulich School of Medicine and Dentistry, London, ON, Canada
Daniel Adam Breadner , Frances Whiston , Larry Stitt , Stephen Welch
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 34, 2016 (suppl 4S; abstr 752)
DOI
10.1200/jco.2016.34.4_suppl.752
Abstract #
752
Poster Bd #
N5
Abstract Disclosures
Similar Posters
Poster
2020 Gastrointestinal Cancers Symposium
The influence of adjuvant chemotherapy dose intensity on overall survival in resected colon cancer: A multicenter retrospective analysis.
First Author: Suganija Lakkunarajah
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Changes in prescribing patterns in stage III colon cancer (CC) since the IDEA collaboration.
First Author: Daniel Walden
Poster
2016 Gastrointestinal Cancers Symposium
Efficacy and feasibility of S-1 plus oxaliplatin (C-SOX) for stage III colon cancer patients who underwent curative resection (KSCC1303).
First Author: Nobutomo Miyanari
Poster
2016 Gastrointestinal Cancers Symposium
“Real world” effectiveness of different postoperative adjuvant chemotherapy regimens in stage III colon cancer patients.
First Author: Jy Ming Chiang